Collaborative Arrangement, Maximum Contingent Payments, Amount

No definition available.

Name:	amrx_CollaborativeArrangementMaximumContingentPaymentsAmount
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Collaborative Arrangement, Profit Share, Percentage

+ References

No definition available.

+ Details

Name:	amrx_CollaborativeArrangementProfitSharePercentage
Namespace Prefix:	amrx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Arrangement, Term

+ References

No definition available.

+ Details

Name:	amrx_CollaborativeArrangementTerm
Namespace Prefix:	amrx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative arrangement, up-front payment.

+ References

No definition available.

+ Details

Name:	amrx_CollaborativeArrangementUpfrontPayment
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Development and regulatory milestones amount.

+ References

No definition available.

+ Details

Name:	amrx_DevelopmentAndRegulatoryMilestonesAmount
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Finance lease expense.

+ References

No definition available.

+ Details

Name:	amrx_FinanceLeaseExpense
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Lessee, Operating Lease, Annual Rent Increase, Percent

+ References

No definition available.

+ Details

Name:	amrx_LesseeOperatingLeaseAnnualRentIncreasePercent
Namespace Prefix:	amrx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of ownership interest.

+ References

No definition available.

+ Details

Name:	amrx_PercentageOfOwnershipInterest
Namespace Prefix:	amrx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Related Party Transaction, Additional Amount Due From Related Parties, If Circumstances Met

+ References

No definition available.

+ Details

Name:	amrx_RelatedPartyTransactionAdditionalAmountDueFromRelatedPartiesIfCircumstancesMet
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Related Party Transaction, Additional Amount Due From Related Parties, If Circumstances Met, Number Of Products

+ References

No definition available.

+ Details

Name:	amrx_RelatedPartyTransactionAdditionalAmountDueFromRelatedPartiesIfCircumstancesMetNumberOfProducts
Namespace Prefix:	amrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Due to other related parties, if circumstances met.

+ References

No definition available.

+ Details

Name:	amrx_RelatedPartyTransactionAdditionalAmountDueToOtherRelatedPartiesIfCircumstancesMet
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Related Party Transaction, Financing Lease, Number Of Buildings

+ References

No definition available.

+ Details

Name:	amrx_RelatedPartyTransactionFinancingLeaseNumberOfBuildings
Namespace Prefix:	amrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Related Party Transaction, Number Of Lease Agreements

+ References

No definition available.

+ Details

Name:	amrx_RelatedPartyTransactionNumberOfLeaseAgreements
Namespace Prefix:	amrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Upfront payment.

+ References

No definition available.

+ Details

Name:	amrx_UpfrontPayment
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.10(3))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.3)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

+ Details

Name:	us-gaap_DueFromRelatedParties
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(11))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3)(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

+ Details

Name:	us-gaap_DueFromRelatedPartiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).

+ References

+ Details

Name:	us-gaap_DueToRelatedPartiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying amount as of the balance sheet date of obligations due all related parties.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(3),(4))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name:	us-gaap_DueToRelatedPartiesCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980

+ Details

Name:	us-gaap_LesseeOperatingLeaseRenewalTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of transactions with related party during the financial reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

+ Details

Name:	us-gaap_RelatedPartyTransactionAmountsOfTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.

+ References

+ Details

Name:	us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07.1(c))
-URI http://asc.fasb.org/extlink&oid=116637345&loc=SL114874292-224272

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

+ Details

Name:	us-gaap_RevenueFromRelatedParties
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=amrx_KashivBioSciencesLicenseAndCommercializationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	amrx_MilestonePaymentAxis=amrx_RegulatoryApprovalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	amrx_MilestonePaymentAxis=amrx_SuccessfulDeliveryOfCommercialLaunchInventoryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=amrx_KashivProductDevelopmentAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	amrx_MilestonePaymentAxis=amrx_AchievementOfCumulativeNetSalesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	amrx_MilestonePaymentAxis=amrx_DevelopmentMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	amrx_MilestonePaymentAxis=amrx_NumberOfCompetitorsForLaunchOfOneProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amrx_KashivBioSciencesLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=srt_AffiliatedEntityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=amrx_KashivBioSciencesLicensingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_ResearchAndDevelopmentReimbursementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amrx_KananLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_AnnualRentalCostMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_RentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amrx_AsanaBiosciencesLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amrx_IndustrialRealEstateHoldingsNYLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_RentRenewalFeeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_DevelopmentAndCommercializationReimbursableExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_CostOfGoodsSoldMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amrx_KashivPharmaceuticalsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_ProfitShareOnVariousArrangementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_LegalCostReimbursementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amrx_PharmaSophiaLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amrx_FosunInternationalLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_NonRefundableFeeNetOfTaxMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=amrx_FeeDueUponFirstCommercialSaleOfProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amrx_AvtarInvestmentsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amrx_ZepIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amrx_ApaceKYLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amrx_TracyPropertiesLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amrx_AzaTechPharmaLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amrx_AvPropLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amrx_AvKAREAndRSMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=amrx_RondoPartnersLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Related Party Transactions - Additional Information (Details)		1 Months Ended				3 Months Ended		6 Months Ended		12 Months Ended
	Oct. 01, 2017	May 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Jul. 31, 2019 USD ($)	Oct. 31, 2017 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2020 USD ($) building lease_agreement	Jun. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)	Jun. 06, 2019 USD ($) product
Related Party Transaction [Line Items]
Related party receivables			$ 1,767,000			$ 1,164,000		$ 1,164,000		$ 1,767,000
Related party payable - short term			5,969,000			8,455,000		8,455,000		5,969,000
Kashiv Bio Sciences License and Commercialization Agreement
Related Party Transaction [Line Items]
Collaborative arrangement term	10 years
Collaborative arrangement, upfront payment					$ 2,000,000
Collaborative arrangement, profit share (percent)					50.00%
Kashiv Bio Sciences License and Commercialization Agreement \| Regulatory Approval
Related Party Transaction [Line Items]
Collaborative arrangement maximum contingent payments amount					$ 21,000,000
Kashiv Bio Sciences License and Commercialization Agreement \| Successful Delivery of Commercial Launch Inventory
Related Party Transaction [Line Items]
Collaborative arrangement maximum contingent payments amount					43,000,000
Kashiv Product Development Agreement
Related Party Transaction [Line Items]
Collaborative arrangement, upfront payment		$ 300,000
Kashiv Product Development Agreement \| Regulatory Approval
Related Party Transaction [Line Items]
Collaborative arrangement maximum contingent payments amount		300,000
Kashiv Product Development Agreement \| Achievement of Cumulative Net Sales
Related Party Transaction [Line Items]
Collaborative arrangement maximum contingent payments amount		1,000,000
Kashiv Product Development Agreement \| Development Milestones
Related Party Transaction [Line Items]
Collaborative arrangement maximum contingent payments amount		$ 800,000
Minimum \| Kashiv Bio Sciences License and Commercialization Agreement \| Number of Competitors for Launch of one Product
Related Party Transaction [Line Items]
Collaborative arrangement maximum contingent payments amount					20,000,000
Minimum \| Kashiv Bio Sciences License and Commercialization Agreement \| Achievement of Cumulative Net Sales
Related Party Transaction [Line Items]
Collaborative arrangement maximum contingent payments amount					15,000,000
Maximum \| Kashiv Bio Sciences License and Commercialization Agreement \| Number of Competitors for Launch of one Product
Related Party Transaction [Line Items]
Collaborative arrangement maximum contingent payments amount					50,000,000
Maximum \| Kashiv Bio Sciences License and Commercialization Agreement \| Achievement of Cumulative Net Sales
Related Party Transaction [Line Items]
Collaborative arrangement maximum contingent payments amount					$ 68,000,000
Kashiv BioSciences LLC \| Related Party
Related Party Transaction [Line Items]
Expenses from transactions with related party										0
Kashiv BioSciences LLC \| Related Party \| Maximum
Related Party Transaction [Line Items]
Expenses from transactions with related party						100,000		$ 100,000
Related Party
Related Party Transaction [Line Items]
Number of buildings, financing lease \| building								2
Lease costs						2,000,000	$ 2,000,000	$ 3,000,000	$ 4,000,000
Related Party \| Kashiv Bio Sciences Licensing Agreement
Related Party Transaction [Line Items]
Upfront payment			2,000,000
Development and regulatory milestones amount			17,000,000							17,000,000
Related Party \| R&D Reimbursement \| Kashiv Bio Sciences Licensing Agreement
Related Party Transaction [Line Items]
Expenses from transactions with related party								$ 2,000,000
Related Party \| Kanan, LLC
Related Party Transaction [Line Items]
Number of lease agreements \| lease_agreement								2
Related Party \| Kanan, LLC \| Annual Rental Cost
Related Party Transaction [Line Items]
Amounts of transaction with related party								$ 2,000,000
Related Party \| Kanan, LLC \| Rent Expense
Related Party Transaction [Line Items]
Expenses from transactions with related party						500,000	500,000	1,000,000	1,000,000
Related Party \| Asana Biosciences, LLC
Related Party Transaction [Line Items]
Income from related parties							1,000,000	0	1,000,000
Related party receivables			1,000,000			0		0		1,000,000
Related Party \| Industrial Real Estate Holdings NY, LLC
Related Party Transaction [Line Items]
Lease renewal term		5 years
Related Party \| Industrial Real Estate Holdings NY, LLC \| Rent Renewal Fee
Related Party Transaction [Line Items]
Expenses from transactions with related party		$ 100,000
Related Party \| Industrial Real Estate Holdings NY, LLC \| Rent Expense
Related Party Transaction [Line Items]
Expenses from transactions with related party		$ 100,000				300,000	300,000	600,000	600,000
Annual rent increase (percent)		3.00%
Related Party \| Kashiv BioSciences LLC
Related Party Transaction [Line Items]
Related party receivables			100,000			100,000		100,000		100,000
Related party payable - short term			6,000,000			4,000,000		4,000,000		6,000,000
Related Party \| Kashiv BioSciences LLC \| Development And Commercialization Reimbursable Expense
Related Party Transaction [Line Items]
Amounts of transaction with related party						0	2,000,000	200,000	3,000,000
Related Party \| Kashiv BioSciences LLC \| R&D Reimbursement
Related Party Transaction [Line Items]
Expenses from transactions with related party						0	0		0
Related Party \| Kashiv BioSciences LLC \| Cost Of Goods Sold
Related Party Transaction [Line Items]
Expenses from transactions with related party						2,000,000		3,000,000		0
Related Party \| Kashiv Pharmaceuticals LLC \| Profit Share On Various Arrangements
Related Party Transaction [Line Items]
Expenses from transactions with related party						2,000,000	700,000	5,000,000	1,000,000
Related Party \| Kashiv Pharmaceuticals LLC \| Legal Cost Reimbursement
Related Party Transaction [Line Items]
Amounts of transaction with related party				$ 2,000,000
Additional amount due to related party, if circumstances met (up to)						18,000,000		18,000,000
Related Party \| PharmaSophia, LLC
Related Party Transaction [Line Items]
Income from related parties						200,000	$ 300,000	400,000	$ 600,000
Related party receivables			700,000			700,000		700,000		700,000
Related Party \| PharmaSophia, LLC \| Maximum
Related Party Transaction [Line Items]
Related parties payable (less than)			$ 100,000							100,000
Related Party \| Fosun International Limited \| Profit Share On Various Arrangements
Related Party Transaction [Line Items]
Income from related parties						0		0
Related Party \| Fosun International Limited \| Non-Refundable Fee, Net of Tax
Related Party Transaction [Line Items]
Payment received, non-refundable fee				$ 1,000,000
Related Party \| Fosun International Limited \| Fee Due Upon First Commercial Sale Of Products
Related Party Transaction [Line Items]
Additional amount due from related parties upon sale of each product											$ 300,000
Additional amount due from related parties upon sale of each product, number of products \| product											8
Related Party \| Avtar Investments, LLC
Related Party Transaction [Line Items]
Expenses from transactions with related party						800,000		800,000
Related parties payable (less than)						800,000		800,000
Related Party \| Zep Inc.
Related Party Transaction [Line Items]
Income from related parties		$ 400,000
Related party receivables						400,000		400,000
Apace KY, LLC
Related Party Transaction [Line Items]
Expenses from transactions with related party						4,000,000		6,000,000		0
Related party payable - short term						1,000,000		1,000,000
Tracy Properties LLC
Related Party Transaction [Line Items]
Expenses from transactions with related party						100,000		200,000		0
AzaTech Pharma LLC
Related Party Transaction [Line Items]
Expenses from transactions with related party						1,000,000		2,000,000		$ 0
Related party payable - short term						700,000		700,000
AvPROP, LLC
Related Party Transaction [Line Items]
Expenses from transactions with related party						$ 100,000		$ 100,000
AvKARE, LLC \| Rondo
Related Party Transaction [Line Items]
Ownership interest (percent)						34.90%		34.90%